Accelerating Drug Discovery

Lupus Therapeutics was established to advance lupus clinical research by finding more effective and safer treatments for people living with lupus. In well over half a century only one new drug has been approved to treat this disease; this is not good enough. We are committed to finding and illuminating promising new treatment opportunities, and ultimately delivering them to lupus patients in just years, not decades.

This is an aspirational investment that we invite every stakeholder in the lupus community to take part in—patients, doctors, researchers and industry.

Lupus Clinical Investigators Network (LuCIN) Site Locations

LuCIN is an academic-based clinical trials network comprised of some of the most prestigious medical research centers and experienced lupus physician-scientists throughout North America.

Click on State or Province to zoom. Click on the site location for more information.

Watch this video to learn more about Lupus Therapeutics and
find out why it will bring us better treatments for lupus faster.

Lupus Therapeutics News

Lupus Research Alliance: Disappointed...

September 4, 2018 The Lupus Research Alliance is disappointed with the results announced by AstraZeneca and MedImmune of the clinical trial testing...

Read More

Lupus Research Alliance LuCIN...

NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance today announced the first clinical trials to be conducted through its...

Read More

Lupus Research Alliance Launches...

NEW YORK, NY — The Lupus Research Alliance launched a bold initiative, the Lupus Clinical Investigators Network (LuCIN) to accelerate the identification and development of new...

Read More

Contact Us

Lupus Therapeutics mission is to accelerate drug discovery and diagnostic innovation for all patients living with lupus. If you would like to learn more please contact us:

Learn more about ongoing clinical trials being conducted within LuCIN